跳至主要内容
临床试验/NCT01818934
NCT01818934已完成不适用

Ultrasound Screening for Developmental Dysplasia of the Hip in the Neonate: The Effect on Treatment Rate and Prevalence of Late Cases

University of Bergen2 个研究点 分布在 1 个国家目标入组 11,925 人开始时间: 2013年3月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
11,925
试验地点
2
主要终点
prevalence of DDH detected after newborn period

研究概览

简要总结

The aim of the randomized controlled trial was to determine whether the addition of a general or of a selective ultrasound screening program resulted in more appropriate criteria for treatment and a reduced prevalence of late DDH compared with clinical examination alone.

详细描述

This is a retrospective registration of a RCT carried out in 1988-90, with a IRB approved follow-up at skeletal maturity carried out in 2007-09. Both the RCT and the follow-up study were carried out in the same institution, by the same PI (Prof. Karen Rosendahl) and her co-workers.

Detailed information is published in the following paper:

Rosendahl K, Markestad T, Lie RT. Ultrasound screening for developmental dysplasia of the hip in the neonate: the effect on treatment rate and prevalence of late cases. Pediatrics 1994;94:47-52.

A sample of the initial RCT was invited for a maturity review/follow-up at skeletal maturity.

The follow-up at skeletal maturity is called:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
— 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • all babies born at our institution during 1/1988-06/1990

排除标准

  • low birthweight <1500 grams, severe malformations, death within first month

研究组 & 干预措施

expert clinical exam only

Active Comparator

all babies assigned to this group had expert clinical examination only, no hip ultrasound

干预措施: hip ultrasound (Procedure)

selective hip ultrasound screening

Active Comparator

all children classified at increased risk, based on clinical findings and/or risk factors (breech presentation, family history, foot deformity)received a hip ultrasound at birth, in addition to expert clinical screening

干预措施: hip ultrasound (Procedure)

universal hip ultrasound screening

Active Comparator

All newborns assigned to this arm received hip ultrasound at birth in addition to expert clinical examination

干预措施: hip ultrasound (Procedure)

结局指标

主要结局

prevalence of DDH detected after newborn period

时间窗: 20 years

prevalence of late cases of DDH, detected after newborn period (after first month of age, including in childhood as assessed in original RCT during 1988-90, with a minimum follow-up time of 27 months, and also at skeletal maturity, as assessed in follow-up study during 2007-09.

次要结局

  • treatment rate(20 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lene Bjerke Laborie

MD, Phd

University of Bergen

研究点 (2)

Loading locations...

相似试验